InflaRx NV (FRA:IF0)
€ 1.337 0.018 (1.36%) Market Cap: 85.54 Mil Enterprise Value: 2.73 Mil PE Ratio: 0 PB Ratio: 0.89 GF Score: 30/100

Q3 2019 Inflarx NV Earnings Call Transcript

Nov 07, 2019 / 01:00PM GMT
Release Date Price: €2.44 (+1.67%)
Laurie Doyle;MC Services AG;Media Relations

Hello, everyone. My name is Laurie Doyle, and I would like to welcome you to the InflaRx conference call to discuss the results from the open-label extension part of the SHINE study with IFX-1 and to provide a strategy update.

On the call today are InflaRx' CEO, Dr. Niels Riedemann; and CFO, Arnd Christ.

On this call, InflaRx will make forward-looking statements, which are statements regarding the company's intentions, beliefs, projections, outlook, analyses and current expectations concerning its business. For a discussion of risks and uncertainties that could cause actual results to differ from such forward-looking statements, please refer to the factors described under the heading Risk Factors in InflaRx' annual report on Form 20-F that was filed with the U.S. Securities and Exchange Commission. Also please refer to the notice and disclaimer associated with the slide deck for this presentation. These statements speak only as of today, and we assume no obligation to update these forward-looking statements even if

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot